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ABSTRACT Gut viruses are important, yet often neglected, players in the complex
human gut microbial ecosystem. Recently, the number of human gut virome studies
has been increasing; however, we are still only scratching the surface of the
immense viral diversity. In this study, 254 virus-enriched fecal metagenomes from
204 Danish subjects were used to generate the Danish Enteric Virome Catalog
(DEVoC) containing 12,986 nonredundant viral scaffolds, of which the majority was
previously undescribed, encoding 190,029 viral genes. The DEVoC was used to com-
pare 91 healthy DEVoC gut viromes from children, adolescents, and adults that were
used to create the DEVoC. Gut viromes of healthy Danish subjects were dominated
by phages. While most phage genomes (PGs) only occurred in a single subject, indi-
cating large virome individuality, 39 PGs were present in more than 10 healthy sub-
jects. Among these 39 PGs, the prevalences of three PGs were associated with age.
To further study the prevalence of these 39 prevalent PGs, 1,880 gut virome data
sets of 27 studies from across the world were screened, revealing several age-, geog-
raphy-, and disease-related prevalence patterns. Two PGs also showed a remarkably
high prevalence worldwide—a crAss-like phage (20.6% prevalence), belonging to the
tentative AlphacrAssvirinae subfamily, and a previously undescribed circular temper-
ate phage infecting Bacteroides dorei (14.4% prevalence), called LoVEphage because
it encodes lots of viral elements. Due to the LoVEphage’s high prevalence and nov-
elty, public data sets in which the LoVEphage was detected were de novo assembled,
resulting in an additional 18 circular LoVEphage-like genomes (67.9 to 72.4 kb).
IMPORTANCE Through generation of the DEVoC, we added numerous previously
uncharacterized viral genomes and genes to the ever-increasing worldwide pool of
human gut viromes. The DEVoC, the largest human gut virome catalog generated
from consistently processed fecal samples, facilitated the analysis of the 91 healthy
Danish gut viromes. Characterizing the biggest cohort of healthy gut viromes from
children, adolescents, and adults to date confirmed the previously established high
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interindividual variation in human gut viromes and demonstrated that the effect of
age on the gut virome composition was limited to the prevalence of specific phage
(groups). The identification of a previously undescribed prevalent phage illustrates
the usefulness of developing virome catalogs, and we foresee that the DEVoC will
benefit future analysis of the roles of gut viruses in human health and disease.
KEYWORDS human gut virome, virome catalog, healthy gut viromes, phages
Gut microbiota, consisting of bacteria, archaea, viruses, fungi, and other eukaryoticmicroorganisms, play a major role in human health and disease (1, 2). Both struc-
tural and functional imbalances of the gut bacteria, called dysbiosis, have been associ-
ated with diseases such as obesity (3), diabetes (4, 5), inflammatory bowel disease (IBD)
(6), cancer (7), and neurological diseases (8). At the same time, research on human gut
viruses, collectively called gut virobiota, is still in its infancy (9), although recent studies
demonstrated associations with IBD (10, 11), diabetes (12, 13), liver disease (14, 15),
and cancer (16).
Only a minority of the human gut virobiota consists of eukaryotic viruses, infecting
human cells, fungal cells, and unicellular eukaryotes residing in the gut or infecting
plant or animal cells transiting as part of the diet (17). The vast majority of viruses in
the human gut are bacteriophages (phages), which rely on a bacterial host to repro-
duce (18). The close interplay between phages and bacteria, which are already impli-
cated in numerous diseases, combined with the ability of gut viruses to directly inter-
act with the human host (19, 20), led to gut viruses gaining more interest as potential
disease biomarkers (16) and treatments for disease (21, 22). It is therefore important to
shed more light on the virobiota, and their collective genomes referred to as the
virome, as this will pave the way to unravelling complex interactions within the gut
microbiota and their effect on the human host (23).
Recent progress in high-throughput sequencing technologies, viral enrichment pro-
cedures, and development of downstream viral bioinformatic tools has facilitated
human gut virome studies investigating their association with health (24–29) or dis-
ease (30–34), as well as their dynamics (18). However, several significant challenges in
studying human gut viromes remain (23). Most importantly, identification of viruses
from metagenomes is hampered by incomplete databases (23) and therefore requires
specialized viral identification tools, e.g., VirSorter (35), MetaPhinder (36), and
DeepVirFinder (37), that do not (only) rely on similarity to known viral genomes/pro-
teins but also look at genome structure to detect viral signatures. High viral mutation
rates cause immense viral genetic diversity (38), thereby complicating viral identifica-
tion based on homology to reference genomes. Even though a few virome databases
recently emerged, they are often not gut-specific (IMG/VR [39], Reference Viral
DataBase [RVDB; 40] and Earth’s virome [41]) or focus only on phages or eukaryotic
viruses (Gut Phage Database [GPD; 42], a “circular” phage database [43], and RVDB
[40]). However, despite these developments, a large fraction of sequences originating
from human gut virome studies cannot be identified as viral because they are not pres-
ent in databases and are therefore called “viral dark matter” (23). Moreover, taxonomic
characterization of human gut viruses is virtually impossible due to the major propor-
tion of viruses being taxonomically unclassified (44, 45), despite ongoing efforts by the
International Committee for the Taxonomy of Viruses (ICTV) (46). Thus, viral taxonomic
analysis is mostly performed on scaffold level or on artificial taxonomic levels gener-
ated by gene-sharing tools, e.g., vConTACT2 (47) or GRAViTy (48). Finally, the lack of
host information and functional annotation of proteins complicates the characteriza-
tion of the phages and their interactions with bacteria in the gut (23, 49). The technical
difficulties of identifying and characterizing viruses are numerous. Nevertheless, it is
important to make progress in generating human gut virome catalogs and characteriz-
ing them to shed light on the viral dark matter. This was exemplified by the discovery
of crAssphages from the cross-assembly of human gut metagenomes across publicly
available data sets (50). This novel group of phages is now believed to be one of the
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most prevalent viruses of the human gut (51, 52). Additionally, a recent study showed
that human gut viromes are highly individual (29), emphasizing the importance of cat-
aloging viromes from diverse human populations.
In this study, we characterized 254 fecal viral metagenomes from Danish children
and adolescents (6 to 18 years old) and adults (aged 40 to 73 years old), to develop the
Danish Enteric Virome Catalog (DEVoC). The DEVoC facilitated assessment of the diver-
sity of the healthy Danish gut viromes, a population in which gut viromes have not
been characterized before. Some phage genomes (PGs) were associated with age,
while other PGs were present in human gut viromes worldwide. In particular, a previ-
ously undescribed PG, which we named LoVEphage, was prevalent in both the healthy
Danish subjects and in publicly available human gut viromes. These insights, as well as
the DEVoC, will further improve our understanding of the role of viruses in the human
gut microbiota and thus human health.
RESULTS
A catalog of 12,986 nonredundant viral scaffolds derived from Danish fecal
viromes encoding 190,029 proteins. The Danish Enteric Virome Catalog (DEVoC) was
constructed based on 254 Danish fecal viromes (3.86 billion raw reads). The viral scaffolds
constituting the DEVoC ranged in size from 1 kb to 191 kb (N50, 16 kb; L50, 1,463 scaffolds),
of which 1,867 viral scaffolds (14.4%) were more than 50% complete as estimated by
CheckV (53). This small subset of viral scaffolds, however, dominates these Danish fecal
viromes, as they represented 87.4% of the total amount of viral reads (Fig. S1A).
Phages represented the vast majority of DEVoC scaffolds (n = 12,771; 98.3%; Fig. 1A)
and viral reads (99.2%). The phage scaffolds were clustered using vConTACT2 to generate
viral clusters (VCs) as a proxy for viral subfamilies or genera. vConTACT2 formed 1,488 VCs
covering 5,222 phage scaffolds (41% of the DEVoC phage scaffolds) representing 73% of
the phage reads (Fig. S1B). Merely 176 phage scaffolds (1.4%) could be taxonomically clas-
sified based on clustering with RefSeq genomes (30 VCs)—3 crAss-like genomes (1 VC),
19 Microviridae genomes (3 VCs), 1 Autographiviridae genome (1 VC), 8 Podoviridae (3
VCs), 16 Myoviridae (6 VCs), and 129 Siphoviridae genomes (16 VCs). Bacterial hosts were
identified using CRISPR spacers for 963 phage scaffolds (7.5%). At the phylum level,
Firmicutes (n = 758) and Bacteroidetes (n = 121) accounted for the largest fractions of
hosts (Fig. 1B), while Faecalibacterium (n = 226), Bacteroides (n = 62), Ruminococcus
(n = 58), and Bifidobacterium (n = 51) were the most common host genera.
A small subset of the DEVoC scaffolds represented viruses infecting eukaryotes
(n = 215; 1.7%). Most putative eukaryotic viral scaffolds (65.6%) belonged to the
FIG 1 DEVoC mainly consists of undescribed phages. (A) Overview of the DEVoC scaffolds (n = 12,986) by type of virus and phage family. (Breakdown of
the eukaryotic viruses into families is visualized in Fig. S3). (B) Overview of the DEVoC phages (n = 12,771) by phylum of the predicted bacterial host. (C)
Venn-diagram showing the number of clusters with members of the DEVoC, GVD, IMG/VR2, and ViralRefSeq databases at 95% identity over 80% coverage.
Numbers in the Venn diagram do not sum up to the database sizes, as a viral sequence from one database may cluster with multiple partial sequences
from a second database; 2,319 sequences in DEVoC, 1,018 in GVD, 544 in IMG/VR2, and 2 in ViralRefSeq were merged in this manner.
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Picobirnaviridae family (subject to interpretation, as increasing evidence suggests that
viruses belonging to this family are phages [54]). The remaining putative eukaryotic vi-
ral genomes belonged to plant-infecting viral families probably originating from the
diet (Alphaflexiviridae [0.9%], Betaflexiviridae [1.4%], Bromoviridae [1.4%], Partitiviridae
[7.0%], Tombusviridae [0.5%], Tymoviridae [0.5%], and Virgaviridae [5.1%]), fungi-infect-
ing viral families (Chrysoviridae [1.4%] and Totiviridae [2.8%]), and viral families that are
known or hypothesized to infect mammals (Anelloviridae [0.9%], Caliciviridae [1.4%],
Circoviridae [5.1%], Genomoviridae [2.3%], Parvoviridae [0.5%], Picornaviridae [2.3%],
and Smacoviridae [0.5%]) (Fig. S2A).
To understand the functional potential of the viruses in the DEVoC, we predicted vi-
ral genes and annotated them using Cenote-Taker 2 (49). The 190,029 DEVoC genes
ranged in size from 0.06 to 18.2 kb (median, 0.34 kb; interquartile range [IQR], 0.19 to
0.62 kb), and 91.3% were complete. About half of the DEVoC genes (n = 102,018;
53.7%) were functionally annotated, with the most common predicted annotations
being major capsid protein, portal protein, large terminase, integrase, and minor cap-
sid protein, all typical phage functions. The DEVoC proteins were clustered using
Proteinortho (55) and formed 18,473 orthologous groups (OGs), containing up to 360
members (median, 3 members; IQR, 2 to 6 members) covering 140,581 DEVoC proteins
(74%). The remaining 49,448 proteins (26%) remained singletons (regarded as OGs
with one member from now on).
The majority of the DEVoC scaffolds are previously undescribed. We compared
DEVoC scaffolds to existing viral genome databases to assess their novelty. Viral scaf-
folds from the NCBI RefSeq v201 database (n = 10,313), the human Gut Virome
Database (18) (GVD; n = 33,242), and the human gastrointestinal tract subset of the
IMG/VR2 database (56) (n = 18,383) were clustered with the DEVoC scaffolds at 95%
identity over 80% coverage. Each of the databases contained a remarkably large set of
previously undescribed viral sequence clusters (DEVoC, 67.3%; GVD, 86.3%; IMG/VR,
82.1%; ViralRefSeq, 97.4%; Fig. 1C). DEVoC shared the largest number of clusters with
the GVD (n = 2,686 containing 4,583 DEVoC scaffolds), followed by IMG/VR2 (n = 1,610
containing 3,096 DEVoC scaffolds). Only 857 clusters (containing 1,960 DEVoC scaf-
folds) were shared among all three human gut-specific viral genome databases, and
these were all phage clusters. This small overlap between the databases reflects the
high interpersonal, potentially cross-regional, age-spanning variation of the human
gut virome that metagenomic research has merely begun to uncover. A minor fraction
of the DEVoC clusters was shared with ViralRefSeq (n = 85 containing 222 DEVoC scaf-
folds), 62 phage and 23 eukaryotic viral clusters. This limited overlap can be attributed
to the underrepresentation of phages in ViralRefSeq (3,672 phage genomes versus
9,476 eukaryotic virus genomes). In total, all four databases shared 10 viral clusters,
including an uncultured crAssphage, and members of the Siphoviridae (Ceduavirus,
Limdunavirus, Oengusvirus, Skunavirus, and Unaquatrovirus genera) and Myoviridae
(Brigitvirus, Lagaffevirus, Peduovirus, and Toutatisvirus genera) families (Table S1).
Healthy Danish gut viromes are highly individual. The remaining analyses solely
included gut viromes from 91 healthy Danish subjects, including 46 children and ado-
lescents (6 to 18 years old) and 45 adults (40 to 73 years old). Samples that we did not
analyze belong to obese children and adolescents and alcoholic liver disease (ALD)
patients, which are all part of a larger ongoing study. The 91 healthy Danish gut
viromes were dominated by phages (relative abundance versus all viral reads; median,
.99.9%; IQR, 99.8% to 100%; range, 79.4% to 100%). As multiple fragments from the
same genome can hamper phage community-level analysis when they are treated as
separate viruses, we restricted the analysis to phage scaffolds that represented more
than 50% of a genome as determined by CheckV (53) (here referred to as phage
genomes [PGs]). This allows us to limit the analysis to a maximum of one fragment for
any given genome. Within the 91 healthy Danish gut viromes, 7,153 phage scaffolds
(56% of the DEVoC phage scaffolds) were detected, and 1,162 of these were PGs
(62.2% of DEVoC PGs). The PGs recruited a median of 90.2% of the phage reads per
sample (IQR, 78.8% to 94.6%; range, 0.83% to 99.6%). The sample in which PGs
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accounted for 0.83% of phage reads was dominated by one phage scaffold with unde-
termined completeness (.99% of viral reads).
The most prevalent PG was a partial Skunavirus genome detected in 30 subjects
(33% prevalence). Including this PG, only 39 PGs (3.4% of all PGs) occurred in more
than 10 subjects (.12% prevalence; Table S2). This subset of 39 highly prevalent PGs
will be further looked into in the next sections and included six skunaviruses, two epo-
naviruses, and one Limdunavirus, Unaquatrovirus, and crAss-like phage each, while the
remaining 18 highly prevalent PGs remained unclassified. In contrast, more than half of
the PGs were subject-specific (n = 611; 52.6%; Fig. 2A), suggesting that the healthy gut
phageome is highly individual. Within each subject’s phageome, the proportion of sub-
ject-specific PGs (versus all PGs; median, 18.7%; IQR, 14.0% to 24.7%; range, ,0.1% to
40.0%) and their relative abundance (versus all phage reads; median, 13.5%; IQR, 7.3%
to 25.3%; range, ,0.1% to 83.7%) varied greatly. The most abundant PG within each
subject recruited between 0.24% and 83.2% of the phage reads (median, 30.4%; IQR,
20.7% to 44.0%; Fig. 2B), while the 10 most abundant PGs represented the majority of
the phage reads in most subjects (median, 82.4%; IQR, 69.2% to 89.0%; range, 0.83% to
99.5%; Fig. 2B). This suggests that the overall diversity of the phageome can be cap-
tured by the 10 most abundant PGs in most samples.
Few eukaryotic viral species were detected in the gut viromes of healthy subjects
(n = 33). The majority (n = 12) were plant viruses and therefore presumably not stable
members of the gut virome but, rather, transient passengers. The median observed eu-
karyotic viral species richness was barely 1 (IQR, 0 to 3; range, 0 to 9; Fig. S2B), and
most eukaryotic viruses were present in only one or two healthy subjects (Fig. S2C),
suggesting that eukaryotic viruses are highly individual.
At the protein level, all healthy subjects combined harbored 46,620 viral OGs
(68.6% of DEVoC OGs). The majority of OGs were present in only one or two healthy
subjects (Fig. 2C), and the number of OGs in healthy subjects ranged from 282 to 6,397
(median, 2,270; IQR, 1,584 to 2,904). A median of 7.9% of the OGs within each subject
were unique to that subject (IQR, 5.6% to 10.5%; range, 0.5 to 23.8%). Notably, the
most prevalent OG was recovered in almost all subjects (n = 88; 96.7%), and 51 OGs
were found across more than 80% of the subjects (Table S3). The five most prevalent
OGs (prevalence, .93%) were predicted to encode a recombination protein, a nucle-
ase, a reverse transcriptase, a terminase large subunit, and a dUTPase.
Several phage genomes and viral functions are associated with age.We investi-
gated if the virome composition differed between the healthy gut phageomes of the
pediatric (n = 46) and the adult cohort (n = 45) cohorts. PG alpha diversity was not
affected by age group (Wilcoxon-test; observed richness, P = 0.89; Shannon’s diversity,
P = 0.83; Fig. S3A and B), and although age group was significantly associated with PG
FIG 2 Danish gut viromes are highly individual and dominated by a limited number of phages. (A) Bar plot of the prevalence of PGs (n = 1,162) in healthy
Danish subjects (n = 91). PGs occurring in 20 or more subjects are grouped. (B) Boxplots of the fraction of all phage reads taken up by the most dominant
PGs in different healthy Danish subjects (n = 91). (C) Bar plot of the prevalence of the viral OGs (n = 46,620) in healthy Danish subjects (n = 91). OGs
occurring in 20 or more subjects are grouped.
Novel Prevalent Phage in Danish Gut Virome Catalog
September/October 2021 Volume 6 Issue 5 e00382-21 msystems.asm.org 5
beta diversity (permutational multivariate analysis of variance [PERMANOVA]; Jaccard
dissimilarity; P = 0.024), it only explained 1% of the variance and might hence not be
biologically relevant (Fig. 3A). Low percentages of explained variability by the first two
principal components indicated a large interindividual diversity in gut phageomes.
To analyze if the occurrence of individual PGs was associated with age group, we
compared prevalences between the pediatric and the adult group. Among the subset
of the 39 most prevalent PGs (present in more than 10 subjects; .12% prevalence),
PG8 was more common in children and adolescents, while PG7 and PG22 were more
prevalent in adults (Chi-square test; adjusted [adj.] P, 0.05; Table S2).
The genomic structures of all three age-associated PGs are visualized in Fig. S4. PG8
is predicted to encode proteins involved in the activation or suppression of the lyso-
genic cycle, indicating that this phage has a temperate lifestyle. Temperate phages
FIG 3 Age group-associated virome patterns in healthy Danish subjects. (A) Principal-coordinate analysis on Jaccard
dissimilarities between healthy Danish subjects at the PG level (PERMANOVA of age group; R2 = 0.01; P = 0.024).
Subjects are colored by age group. (B) Boxplots of the number of temperate PGs in healthy Danish children and
adolescents (n = 46) and adults (n = 45) (Wilcoxon test; P = 0.034). (C) Boxplots of the proportional richness of
temperate PGs (number of temperate PGs versus total number of PGs) in healthy Danish children and adolescents
(n = 46) and adults (n = 45) (Wilcoxon test; P = 0.0016). (D) Boxplots of Shannon’s diversity of temperate PGs in
healthy Danish children and adolescents (n = 46) and adults (n = 45) (Wilcoxon test; P = 0.018). (E) Principal-coordinate
analysis on Jaccard dissimilarities between healthy Danish subjects at the OG level (PERMANOVA of age group; R2 = 0.03;
P = 0.001). Subjects are colored by age group. All analyses are performed on 46 children/adolescents and 45 adults.
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have the potential to alter the bacterial host phenotype and shift the dynamics of the
complex gut microbial network. Therefore, we identified lysogeny-associated genes
(listed in Table S4) in the PGs and classified 345 temperate PGs in the healthy Danish
subjects (29.7%). Each subject had a median of 11 different temperate PGs (IQR, 6.5 to
15; range, 0 to 27), representing roughly one-third of a subject’s PGs (median, 31.6%,
IQR, 21.5% to 39.5%; range, 0 to 66.7%) and accounting for a median of 19.3% of the
PG reads (IQR, 8.8% to 42.6%; range, 0% to 95.3%). Among the temperate PGs, the
alpha-diversity measures observed (absolute) richness, proportional (versus all PGs)
richness, and Shannon diversity were higher in children/adolescents than in adults
(Wilcoxon test; P = 0.034, P = 0.0016 and P = 0.018, respectively; Fig. 3B to D), while we
did not observe a difference in the relative abundance of temperate PG (versus all
phage reads; P = 0.21; Fig. S3C).
We further assessed the association between age group and viral functions repre-
sented by OGs. Similar to the previous analysis, the observed richness of viral OGs did
not differ between age groups (Wilcoxon test; P = 0.11; Fig. S3D). However, age group
explained 3% of the beta diversity between subjects (Jaccard dissimilarity;
PERMANOVA; P = 0.001; Fig. 3E). Analysis of all OGs containing two or more members
and present in more than 10 healthy subjects (n = 3,627) identified 29 OGs with a
higher prevalence in one or both age groups (Chi-squared test; adj. P , 0.05; Table 1).
Interestingly, only one OG (a putative metallopeptidase) was detected more often in
adults, while the remaining OGs were more common in the pediatric cohort.
Highly prevalent DEVoC phage genomes are detected worldwide. We further
examined whether the subset of 39 highly prevalent PGs defined earlier in the healthy
Danish subjects (Table S2) could be recovered worldwide, across age groups and
TABLE 1 Orthologous groups with age-associated absence/presence profiles
Orthologous
group identifier Size Annotation Function










OG_17005 180 Hypothetical protein Unknown 63 (69.2) 42 (91.3) 21 (46.7) 0.0011
OG_17212 205 Carlavirus endopeptidase Assembly 63 (69.2) 42 (91.3) 21 (46.7) 0.0011
OG_116 149 Tail assembly chaperone protein Assembly 58 (63.7) 40 (87) 18 (40) 0.0008
OG_17197 159 Hypothetical protein Unknown 56 (61.5) 42 (91.3) 14 (31.1) , 0.0001
OG_17367 149 Major capsid/head protein Structural 54 (59.3) 41 (89.1) 13 (28.9) , 0.0001
OG_17685 118 Minor structural protein Structural 54 (59.3) 39 (84.8) 15 (33.3) 0.0002
OG_863 115 Hypothetical protein Unknown 49 (53.8) 36 (78.3) 13 (28.9) 0.0006
OG_16990 86 Hypothetical protein Unknown 46 (50.5) 35 (76.1) 11 (24.4) 0.0002
OG_1899 95 Tail completion protein Assembly 44 (48.4) 35 (76.1) 9 (20) , 0.0001
OG_2871 96 Portal protein Packaging 43 (47.3) 33 (71.7) 10 (22.2) 0.0006
OG_3146 86 Hypothetical protein Unknown 41 (45.1) 32 (69.6) 9 (20) 0.0005
OG_3199 20 Polysaccharide export protein Other 37 (40.7) 31 (67.4) 6 (13.3) , 0.0001
OG_16319 71 tRNA synthase Translation 35 (38.5) 29 (63) 6 (13.3) 0.0003
OG_2045 48 Hypothetical protein Unknown 34 (37.4) 28 (60.9) 6 (13.3) 0.0007
OG_2076 6 Putative metallopeptidase Other 33 (36.3) 5 (10.9) 28 (62.2) 0.0001
OG_752 45 Hypothetical protein Unknown 33 (36.3) 29 (63) 4 (8.9) , 0.0001
OG_16058 4 Hypothetical protein Unknown 32 (35.2) 28 (60.9) 4 (8.9) 0.0001
OG_17591 68 Hypothetical protein Unknown 31 (34.1) 27 (58.7) 4 (8.9) 0.0002
OG_2749 34 Hypothetical protein Unknown 31 (34.1) 26 (56.5) 5 (11.1) 0.0012
OG_1811 3 Plasmid recombination enzyme Recombination 30 (33) 26 (56.5) 4 (8.9) 0.0004
OG_16535 37 LytR response regulator Other 29 (31.9) 25 (54.3) 4 (8.9) 0.0009
OG_17358 59 Hypothetical protein Unknown 27 (29.7) 25 (54.3) 2 (4.4) 0.0001
OG_17353 63 Bromodomain RACK7-like subfamily Other 26 (28.6) 24 (52.2) 2 (4.4) 0.0001
OG_18041 45 Head tail connector protein Structural 26 (28.6) 24 (52.2) 2 (4.4) 0.0001
OG_18129 44 Minor structural protein Structural 24 (26.4) 22 (47.8) 2 (4.4) 0.0008
OG_2613 38 Hypothetical protein Unknown 22 (24.2) 21 (45.7) 1 (2.2) 0.0004
OG_3028 35 Hypothetical protein Unknown 22 (24.2) 21 (45.7) 1 (2.2) 0.0004
OG_2406 37 DNA binding protein Other 20 (22) 20 (43.5) 0 (0) 0.0002
OG_2150 27 Hypothetical protein Unknown 19 (20.9) 19 (41.3) 0 (0) 0.0004
aBonferroni-adjusted P values of chi-squared test on prevalences.
bPrevalences in bold indicate the cohort with the highest prevalence.
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diseases. For this purpose, we obtained 1,880 fecal viral metagenomes from NCBI SRA
(denoted SRA viromes here), deriving from 1,181 subjects (see Table S5 for an overview
of the included studies). The highly prevalent DEVoC PGs were widely detected in SRA
viromes (Fig. 4A). The prevalence of these 39 PGs was significantly associated with the
geographical region (continent of sample collection) of the SRA viromes (Kruskal-Wallis
test; P , 0.0001; Fig. 4B). Our prevalent PGs were found more often in Europeans
(n = 164) than in subjects from the other continents (Wilcoxon signed-rank test; versus
America (n = 170), adj. P , 0.0001; versus Africa (n = 188), adj. P , 0.0001; versus Asia
(n = 20), adj. P = 0.038). Moreover, they exhibited higher prevalence in Americans than
Africans (Wilcoxon signed-rank test; adj. P , 0.0001). Age groups were also signifi-
cantly associated with the prevalence of these PGs (Kruskal-Wallis test; P , 0.0001;
Fig. 4C). Children and adolescents (3 to 17 years old; n = 12) had the lowest prevalence
(Wilcoxon signed-rank test; versus infants [0 to 2 years old; n = 159], adj. P = 0.0054;
versus adults [18 to 64 years old; n = 231], adj. P , 0.0001; versus elderly [$65 years
old; n = 38], adj. P = 0.0001), followed by infants (Wilcoxon signed-rank test; versus
adults, adj. P , 0.0001; versus elderly, adj. P = 0.0025). We did not observe a significant
association between healthy (n = 472) and all diseased (n = 247) subjects (Wilcoxon
rank sum test; P = 0.13). The type of disease did, however, have an effect (Kruskal-
Wallis test; P , 0.0001; Fig. 4D). Remarkably, malnourished Malawian infants (n = 12)
lacked all 39 highly prevalent PGs, and consequently, prevalence was significantly
lower in this group than in all other disease groups besides the HIV patients (Wilcoxon
signed-rank test; versus inflammatory bowel disease [IBD, n = 48], adj. P = 0.0044; ver-
sus type 1 diabetes [T1D, n = 29], adj. P = 0.0117; versus adenoma [n = 28], adj.
P = 0.0010; versus C. difficile infection [CDI, n = 35], adj. P = 0.0035; versus colorectal
carcinoma [CRC, n = 28], adj. P = 0.0056; versus hematopoetic stem cell transplantation
[HSCT, n = 44], adj. P = 0.0004). Furthermore, patients undergoing HSCT (n = 44) had a
higher prevalence than T1D (n = 29; adj. P = 0.0077), IBD (n = 48; adj. P = 0.0003), and
HIV patients (n = 22; adj. P = 0.0246).
A crAss-like phage and a previously undescribed phage were highly prevalent
in healthy Danish subjects and shared across the world. Among the 39 most preva-
lent PGs in the healthy DEVoC subset, two were widely distributed in SRA viromes
(Fig. 4A). A 99-kb circular crAss-like phage (PG2) was the most prevalent in SRA viromes
(20.6% prevalence; Fig. 5A). CrAssphages infect Bacteroidales sp. and are among the
most abundant and globally distributed group of viruses in the human gut (51, 52).
The second most prevalent PG in SRA viromes (PG6; 14.4% prevalence; Fig. 5B), was a
71-kb circular phage without clear homology to previously described phages. Despite
the lack of clear homology, this PG possessed lots of viral (genetic) elements and was
therefore named LoVEphage. The prevalence of these two phages was associated with
age group and geographical location (test of equal proportions between multiple
groups; P , 0.001 for both age group and geographical location for both PG2 and
PG6). None of the two PGs were detected in healthy children/adolescents from other
studies (n = 12), although they were detected in the DEVoC healthy children/adoles-
cents. While they occurred in, respectively, 7.5% and 5% of the infants (n = 159), their
prevalence significantly increased to 32.5% and 20.8% in adulthood (n = 231; test of
equal proportions; PG2, adj. P , 0.00001; PG6, P = 0.00015) and to 42.1% and 28.9% in
the elderly (n = 38; test of equal proportions; PG2, adj. P , 0.0001; PG6, P = 0.00015).
The crAss-like phage was significantly more prevalent in healthy Europeans (n = 164;
34.8% prevalence) and healthy Asians (n = 20; 50% prevalence) than in healthy
Americans (n = 170; 21.1% prevalence; test of equal proportions; adj. P = 0.02445 ver-
sus Europeans; adj. P = 0.02445 versus Asians) while less prevalent in healthy Africans
(n = 118; 3.4% prevalence; test of equal proportions; adj. P, 0.001 versus all other con-
tinents). The LoVEphage was more prevalent in healthy Europeans (n = 164; 20.7%
prevalence) and Americans (n = 170; 18.8% prevalence) than in healthy Africans
(n = 118; 2.5% prevalence; test of equal proportions; versus Europeans, adj.
P = 0.00011; versus Americans, adj. P = 0.00035). Asians (n = 20) had a prevalence of
15% for the LoVEphage (PG6). Additionally, we found that the prevalence of the crAss-
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FIG 4 Worldwide prevalence of the 39 most prevalent healthy Danish PGs. (A) Heatmap of the prevalence of the top 39 most prevalent PGs (rows) in
different subsets of subjects (columns) from this study’s healthy Danish population (columns 1 to 3) and from other human gut virome studies (columns 4
to 19). The first four columns represent the prevalence in healthy Danish subjects, all healthy Danish children and adolescents (6 to 18 years old), and all
healthy Danish adults, including the elderly (40 to 73 years old) from the DEVoC cohort. The fourth column shows the overall prevalence in all subjects
from all the other studies combined. Columns 5 to 13 represent the prevalence in the healthy subjects (column 5), separated by continent (column 6 to 9)
and age group (columns 10 to 13). Columns 14 to 22 represent the prevalence in disease subjects (column 14) in different diseases (column 15 to 22). The
numbers of included subjects (n) and studies (s) are indicated on top of each column. PGs not detected in a specific subset are marked by a blank square.
(B) Boxplots showing the prevalence of the top 39 PGs in different continents. (C) Boxplots showing the prevalence of the top 39 PGs in different age
groups. (D) Boxplots showing the prevalence of the top 39 PGs in different diseases. Prevalences are indicated by different shapes and colors by PG and
connected across boxplots in panels B, C, and D, and the numbers of subjects (n) and studies (s) included in each subgroup are indicated below each
boxplot. PGs with an asterisk are further discussed in Fig. 5. HSCT, hematopoietic stem cell transplantation; CRC, colorectal cancer; CDI, Clostridium difficile
infection; T1D, type 1 diabetes; HIV, human immunodeficiency virus; IBD, inflammatory bowel disease; MN, malnutrition.
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FIG 5 Genomic structure of the identified crAss-like and LoVEphage genomes. (A) The genomic structure of a crAss-like phage (PG2). (B) The genomic
structure of the LoVEphage (PG6). (C) Maximum likelihood trees of concatenated protein alignments (n = 61) of 19 LoVEphage-like genomes recovered
from Danish subjects and SRA viromes. Only bootstrap values higher than 70 are shown. Tip symbol and color are indicative of, respectively, the age group
and country of origin of the individual from which the LoVEphage-like genome was assembled. Disease states are indicated in the tip labels. Full-genome
structures of the 19 LoVEphage-like genomes are visualized next to the phylogenetic tree. ALD, alcohol liver disease; CRC, colorectal cancer; T1D, type 1
diabetes; HSCT, hematopoietic stem cell transplantation. All genomes in panels A, B, and C are represented linearly for clarity, although all have a circular
genome. Arrows indicate ORFs, and annotations for known ORFs are given. Unknown proteins indicate ORFs with no hit to any of the databases. ORFs
without function indicate proteins with hits to hypothetical proteins.
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like phage was affected by disease (test of equal proportions between multiple groups;
P = 0.004). Remarkably, its prevalence was significantly lower in IBD patients (n = 48;
6.3% prevalence) than in CRC patients (n = 28; 39.3% prevalence; test of equal propor-
tions; adj. P = 0.029), while other diseases did not affect its presence.
The circular crAss-like phage (PG2) genome of 99 kb encoded 99 proteins, of which
32 (32.3%) were functionally annotated (Fig. 5A). PG2 was classified as the
AlphacrAssvirinae subfamily, genus I, one of the most prevalent gut viruses in Western
subjects independent of age. Typical of a crAssphage, PG2 was subdivided into two
regions with opposite gene orientation, one region encoding proteins predicted to be
involved in host interaction and phage structure and the other region encoding pro-
teins predicted to be involved in DNA replication, recombination, and nucleotide me-
tabolism. Downstream of the tail collar fiber protein we observed a reverse transcrip-
tase—indicative of a diversity-generating retroelement previously described in
crAssphages (57). No gene was annotated as RNA polymerase; however, we suspect
that one of the large unknown genes may encode a divergent RNA polymerase subu-
nit, as large unannotated proteins in crAss-like phages often contain an amino acid
motif typical for RNA polymerases (58). PG2 had no tRNA genes, otherwise commonly
found in genus I, II, and IV AlphacrAssvirinae.
The LoVEphage (PG6) had a circular 71-kb genome encoding 130 proteins, of which
45 (34.6%) were functionally annotated. Nine tRNA genes were identified in the
LoVEphage, and the orientation of the genes was more random than that of the crAss-
like phage. In this genome, we also observed a tail collar fiber protein, located upstream
of a reverse transcriptase, similar to what we observe in the crAss-like phage (PG2). The
predicted presence of two integrase proteins, a repressor protein, and a prophage protein
suggest that the LoVEphage is a temperate phage. Furthermore, the genome was highly
similar to Bacteroides dorei strain CL03T12C01 (GenBank accession number CP011531.1)
(95.6% nucleotide identity and 96% coverage), indicating that a LoVEphage-like phage
has occurred as prophage in this bacterial genome. Additionally, the Bacteroides genus
was also predicted to be the host for the LoVEphage based on matches with CRISPR
spacers.
To investigate the genetic diversity of the LoVEphage (PG6), 18 additional complete
LoVEphage-like genomes were reconstructed from the DEVoC (3/18) and SRA (15/18)
viromes. Each complete genome (67.9 to 72.4 kb) encoded between 122 and 131
genes, of which 61 conserved proteins were selected for phylogenetic analysis based
on concatenated protein alignment. Two large phylogenetic clusters can be distin-
guished (Fig. 5C). The largest cluster contains 12 genomes mainly obtained from
healthy adults, while the smaller cluster contains 7 genomes from subjects with vari-
able ages and disease states. However, no distinct clustering based on geography, age,
or health status was observed. All 19 genomes show remarkable conservation of syn-
teny (Fig. 5C). The largest gene in these genomes has a conserved position but has
one of three annotations. Four proteins, including the protein from the reference, are
annotated as “mu-like prophage protein” (indicative of temperate phages and involved
in tail assembly; green), while 11 proteins are annotated as “tail tape measure protein”
(involved in tail assembly; yellow) and four proteins, as “reticulocyte binding protein
rhoptry” (a protein involved in the entry of the malaria parasite in red blood cells; pur-
ple). Proteins from the latter two groups show .88% amino acid identity to the pro-
teins annotated as “mu-like prophage protein,” while they show .99% pairwise amino
acid identity. Therefore, we assume that “reticulocyte binding protein rhoptry” is likely
a misannotation in one of the databases used.
DISCUSSION
Human gut viruses represent a major pool of diverse and relatively underexplored
microbes that, together with other gut microbiota, are believed to impact human
health and disease (59). Currently, the number of studies exploring the human gut
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viruses and cataloging their viral genomes and genes is expanding significantly, collec-
tively advancing the virome field.
In this study, a human enteric virome catalog (the DEVoC), containing 12,986 viral scaf-
folds and encoding 190,029 genes, was generated from 254 fecal viromes from Danish
children, adolescents, and adults. The majority of the DEVoC scaffolds originated from
unclassified phages (Fig. 1A) without an assigned bacterial host (Fig. 1B), as described in
other human gut virome databases (18). Even though the viral RefSeq version used dur-
ing vConTACT2 clustering contained the most recently established phage families
Ackermannviridae, Herelleviridae, Chaseviridae, Dexlerviridae, and Demerecviridae, none of
the DEVoC scaffolds formed a viral cluster (VC) with these families. Although less stringent
taxonomical classification approaches could increase the number of phage genomes with
assigned taxonomy, a large fraction of phage scaffolds would remain unclassified none-
theless, hampering potential subsequent analyses at the family/genus level. Hence, fur-
ther analyses were conducted at the individual scaffold level, thereby also avoiding hav-
ing the results become outdated due to the constantly evolving phage taxonomy. DEVoC
phages (Caudovirales and Petitvirales orders) and their bacterial hosts (Firmicutes and
Bacteroidetes phyla) have all been commonly described in the human gut (18, 29, 60, 61).
Recent human gut virome studies concluded gut viromes of healthy Western adults
to be highly individual (27, 29, 62). Individual-differentiating factors likely include geo-
graphical origin (63), age (18), diet (26, 62), and health status (11, 14, 15, 64, 65). Hence,
our findings of large individuality of the gut viromes in healthy Danish adults is
expected. The virome composition of healthy children (.3 years) and adolescents has
not been studied before but is expected to show similar subject specificity since gut
virome individuality has also been observed in infants (25). Due to this high virome
individuality, it is not surprising that the majority of the identified viral genomes were
not previously described, indicating that we are only scratching the surface of the viral
diversity in the human gut microbiota worldwide (Fig. 1C). Notably, the very limited
overlap of DEVoC with viral RefSeq indicates the clear underrepresentation of gut
phages in the RefSeq database.
The DEVoC scaffolds encoded 190,029 genes, of which 53.7% could be annotated.
However, exact estimates of functions were impeded, as multiple descriptions of the
same function exist. To overcome this issue and the problem of unannotated proteins
in general, proteins were clustered into OGs which were used as a proxy for function.
As there is currently no database cataloguing the proteins encoded by gut viral
genomes, the DEVoC encoded proteins could serve as a starting point to study the
functional capacities of human gut viromes.
We further characterized the gut viromes in a subset of Danish healthy children,
adolescents, and adults (n = 91) used to develop the DEVoC. The substantial number
of previously undescribed DEVoC viral genomes is a clear indication of high individual-
ity of human gut viromes and was further reflected by the low prevalence of most PGs
(phage genomes predicted to be at least 50% complete) (Fig. 2A). It should be noted
that in each healthy subject the majority of the viral reads belonged to only a few
phage genomes (Fig. 2B). Despite this virome individuality, we identified 39 PGs pres-
ent in more than 10 healthy subjects (.12% prevalence) with a maximum prevalence
of 33% (30 subjects) (Table S2). This finding refutes the existence of a “core” virome
(phages present in .50% of subjects) (66)—at least at genome level—in line with pre-
vious studies (18). OGs, on the other hand, were much more prevalent and could be
detected in up to 97% of the healthy subjects (Table S3); most of these are involved in
typical phage functions. However, similar to previous findings (67), the majority of the
OGs remained specific to only one subject (Fig. 2C).
Gregory et al. (2020) reported an age-dependent virome diversity using publicly
available data (18). They included studies produced with various wet-lab procedures
and sequencing depths, as well as age groups with unequal age ranges and sample
sizes (infants [,3 years], n = 27, versus children/adolescents [3 to 18 years], n = 11, ver-
sus adults [18 to 65 years], n = 93 versus elderly [.65 years], n = 20). Our study could
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not confirm the former finding, as the PG richness and Shannon diversity did not differ
across age groups (Fig. S3A and B). While our study has the advantage of consistently
processed samples of different age groups (range, 6 to 73 years), we lacked data from
infants, young children (,6 years old), and young adults (19 to 39 years old) to make
associations with age as a continuous variable. OG richness was, similar to PG richness,
not different between age groups (Fig. S8). Beta diversity at the PG and OG levels were
associated with age group, although the biological importance of this effect is prob-
ably limited (Fig. 3A and E). Interestingly, at the level of individual OGs and PGs, 45
OGs and 3 PGs had different prevalences across age groups (Table 1 and Table S2). The
presence of age-associated PGs may indicate that some “common” (prevalence
between 20 and 50%) or even “core” (prevalence higher than 50%) phages (66) might
exist in smaller, more homogeneous, populations, although core phages do not exist
for the general healthy human population. Moreover, while age does not seem to
affect overall diversity of the gut virome, age seems to affect the presence of certain
viruses. The association of specific phages with age group might be linked to the gut
microbiota with the human host, affecting human host metabolism and immune
response.
We observed a clear decrease in the number and proportion of temperate PGs in
our healthy adult population (Fig. 3B and C). This is accordant with the finding from L.
Beller, W. Deboutte, S. Vieira-Silva, G. Falony, R. Yhossef Tito, L. Rymenans, C. Kwe
Yinda, B. Vanmechelen, L. Van Espen, D. Jansen, C. Shi, M. Zeller, P. Maes, K. Faust, M.
Van Ranst, J. Raes, and J. Matthijnssens (unpublished data) that demonstrates a
decrease in the proportion of temperate phages across the first year of life in infants
and suggests that this decrease continues during childhood into adulthood. It should,
however, be noted that the identification of phage genomes with the potential to
enter the lysogenic life cycle will be underestimated, as not all lysogeny-associated
genes are currently known, and genes could also be encoded on the missing frag-
ments of partial phage genomes.
Finally, we investigated the prevalence of the 39 most prevalent healthy Danish
PGs in worldwide gut virome studies (Fig. 4A). Geography, age, and disease were all
associated with the prevalence of the top 39 PGs (Fig. 4B to D). However, the conclu-
sions should be interpreted cautiously, as subsets consisted of heterogeneous sample
sizes. Some patient subsets showed a remarkably high prevalence (e.g., CRC or HSCT
patients) or complete absence (malnourished Malawian infants) of the top 39 PGs.
These striking differences are possibly confounded, as they often consist of a limited
number of samples from only a single study, which can cause a severe bias regarding
sample preparation, sequencing depth, or study setup. The top 39 PGs were, nonethe-
less, most commonly found in other European adults, which could be expected given
the demographic similarity to our cohorts. The top 39 PGs were less commonly
observed in infants, which are known to have a more distinct gut virome composition,
and this age group was not included in the development of the DEVoC. Prevalences
from healthy children and adolescents should be interpreted cautiously, as this SRA
subset contained very few subjects due to the limited availability of these samples. For
the same reason, the age-specific PGs could not be confirmed within the SRA viromes.
The group of crAss-like phages and their high prevalence and abundance across
human gut viromes have been described extensively (51, 68–70). Although not as
widespread as the crAss-like phages, the newly discovered LoVEphage seems to be
rather common as well, with a prevalence of 28.6% in the healthy Danish subjects and
14.4% in the SRA viromes (Fig. 4A). However, the prevalence of crAss-like phages and
the LoVEphages across SRA viromes is probably an underestimate due to the stringent
criteria used and the low sequencing depths of some samples. Despite not having clear
homology to previously described phages, numerous typical phage genes were identi-
fied in the LoVEphage (Fig. 5B). Phylogenetic analysis of 19 LoVEphage genomes did
not reveal any clustering based on age, geography, or disease status (Fig. 5C), in con-
trast to the crAss-like phages, which seem to have some level of local geographic
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clustering (71). However, such patterns may become apparent when more LoVEphage-
like genomes are included/investigated. Future studies should experimentally deter-
mine the host range and morphology of the LoVEphage, as well as their broad genetic
diversity in the general population, to uncover the potential associations of variants
with disease. It could be worthwhile to also investigate whether this phage is specific
to humans or is also found in nonhuman primates and other mammals as is the case
for crAss-like phages (71, 72).
In conclusion, the human gut virome catalog DEVoC and its encoded genes generated
from Danish children, adolescents, and adults assisted in the characterization of the
healthy gut virome and will prove very helpful in investigating the role of the gut virome
in human health and disease in the future. Furthermore, by investigating the presence of
the top healthy Danish PGs in other human gut virome studies, we identified a previously
undescribed phage, called LoVEphage, with a high worldwide prevalence.
MATERIALS ANDMETHODS
Subject recruitment and sample collection. The two Danish cohorts involved in this study were
included as part of the MicrobLiver project. The pediatric cohort included 50 children and adolescents (6
to 18 years old) with a BMI above the 90th percentile, together with 50 age- and sex-matched healthy
controls (73). The obese pediatric subjects were enrolled in an obesity treatment, and samples were
included at baseline and the 1-year follow-up. The adult cohort (34 to 76 years old) included 52 patients
with alcohol-related liver disease (ALD) and 52 sex, BMI, and age-matched healthy controls. They repre-
sent a selection of participants from a study aimed to develop noninvasive markers of early-stage alco-
hol-related liver disease. In total, 254 fecal samples were collected from 204 subjects.
Fecal samples were collected at home and kept at 220°C for 0 to 4 days, after which they were
brought to the clinic (frozen) and stored at 280°C. For the adult cohort, samples were aliquoted at
2120°C with the CryoXtract CXT350 device (CryoXtract Instruments) (74). Fecal samples from the pediat-
ric cohort were aliquoted on ice, as the fecal sample sizes were much smaller. All fecal samples were
kept at 280°C until use.
Sample preparation and sequencing. All 254 fecal samples were prepared for high-throughput
virome sequencing using the NetoVIR protocol (75). In short, each fecal aliquot was homogenized in
phosphate-buffered saline (PBS) (30 mass/volume percentage), centrifuged, filtered (0.8 mm), and sub-
jected to nuclease treatment to enrich for viral-like particles. Next, the QIAamp viral RNA minikit
(Qiagen) without carrier RNA was used to extract both RNA and DNA. The extracts were reverse tran-
scribed and randomly amplified (17 cycles) using a modified WTA2 kit (Sigma-Aldrich). Sequencing libra-
ries were prepared with the Nextera XT DNA library preparation kit (Illumina) and sequenced on the
NextSeq 500 high-throughput Illumina platform (Nucleomics Core facility, KU Leuven, Belgium). Per sam-
ple, a median of 12.1 million (IQR, 6.9 million to 19.4 million) paired-end reads (2  150 bp) were
generated.
Development of the Danish Enteric Virome Catalog. Raw reads were processed as described by L.
Beller et al. (submitted for publication). In short, reads were quality controlled using Trimmomatic
(v0.36) (76), after which reads mapping to the “contaminome” and human genome were removed using
Bowtie2 (v2.3.4.1) in “very-sensitive” mode (77). Quality-filtered reads were de novo assembled, and all
scaffolds longer than 1 kb were clustered at 95% identity over 80% coverage to remove redundancy in
line with Roux et al. (78). Instead of calculating abundances by mapping the quality-filtered reads to the
complete set of nonredundant scaffolds, reads were only mapped against to the representatives of the
clusters containing a scaffold from that sample to avoid false-positive detection of closely related
sequences. A scaffold was assumed to be present if 70% of its length was covered by reads. Scaffolds
representing less than 0.00001% of the total amount of mapped reads across all samples were removed
to reduce background noise. Viral scaffolds were selected to construct the Danish Enteric Virome
Catalog (DEVoC). These viral scaffolds were identified by using a combination of homology to known
viruses at the protein and/or nucleotide level, genome structure (kmer usage and gene content), the
presence of virus-specific genes, and VirSorter category (35). The completeness of viral genomes was
assessed with CheckV (v0.6.0) (53), and viral scaffolds were annotated using Cenote-Taker 2 (v2.0.1; pa-
rameters –prune_prophage False –enforce_start_codon False –hsuite_tool hhsearch) (49).
Taxonomic classification of viral scaffolds. Eukaryotic viruses were classified based on the lowest
common ancestor determined using ktClassifyBLAST (v2.7.1) (79) on DIAMOND protein hits (v0.9.10.111,
sensitive mode) (80) and BLASTn nucleotide hits (v2.7.1; E value, 1e-10) (81) (nonredundant [nr] and nu-
cleotide [nt] databases downloaded from NCBI on 3 May 2019). As taxonomic classifications are unavail-
able for most phage scaffolds, vConTACT2 (v0.9.19) was used to create viral clusters (VCs) based on
gene-sharing networks that represent genus/subfamily-level taxonomy (47). If phage scaffolds clustered
with a RefSeq phage genome (v201), the taxonomy of the RefSeq phage genome(s) was assigned to the
other members of the VC up to genus level.
Phage host prediction. CRISPR spacers were predicted using MinCED (v0.4.2) on the bacterial con-
tigs assembled from shotgun metagenomic sequencing data of the same 254 fecal samples used to gen-
erate the DEVoC (unpublished data) (82). The predicted CRISPR spacers were submitted to a BLAST
search against the phage subset of the DEVoC (-evalue, 1e-10, task, “blastn-short”) (81). Phages required
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at least two spacer matches with a maximum of one mismatch for reliable host assignment as the lowest
common ancestor of the bacterial matches. Bacterial contigs were mapped against ProGenomes2 (83),
and the lowest common ancestor was determined using ktClassifyBLAST (79).
Identification and annotation of DEVoC genes. Cenote-Taker 2 (v2.0.1) was used to predict and
annotate open reading frames (ORFs) on the viral genomes of the DEVoC (49). Cenote-Taker 2 predicts
ORFs using a combination of PHANOTATE (84) and Prodigal (85) in metagenomic mode and annotates
the predicted ORFs using HMMER (86), RPSBLAST, (87) and HHSEARCH (88) searches against custom viral
HMM, CDD, Pfam, and PDB databases. Next, amino acid sequences of the predicted ORFs were clustered
into orthologous groups (OGs) using Proteinortho (v6.0.18) (55) with default settings and DIAMOND
v0.9.32 (80). The annotation(s) given to at least 10% of the protein members of a specific OG was
assigned to that OG of interest (manually, to overcome differences in spelling, capitalization, and abbre-
viations, as well as synonyms of the same protein, due to the use of different databases). This 10%
threshold was introduced to avoid spurious annotations of OGs.
Gene prevalence. Due to the short nature of some DEVoC genes (the lower cutoff length for ORF
identification was 20 amino acids) compared to the read length, we decided against a mapping
approach to determine gene presence per sample. This is because short genes would be underrepre-
sented, as a substantial fraction of the reads would only partially overlap the gene (and therefore not be
assigned) compared to larger genes. Instead, we opted to count a viral gene as present when the corre-
sponding viral genome was present (see L. Beller et al. [submitted for publication] for genome abundan-
ces). The presence of orthologous groups (OGs) was determined by grouping the prevalence informa-
tion of all genes within the specific OG.
Comparison to existing databases. The DEVoC and its encoded genes were compared against
existing (human gut) viral genome databases, including the human Gut Virome Database (GVD, version
2020/07/23) (18), IMG/VR2 (version July 2019) (56), and viral RefSeq (v201, version 10/07/2020). To deter-
mine overlap between the different genome databases (GVD, IMG/VR2, and viral RefSeq) and the
DEVoC, they were clustered with ClusterGenomes (89) at 95% identity over 80% coverage (using nucmer
v3.23) (90). Only IMG/VR2 sequences originating from human digestive tract samples (n = 78,016) were
selected for comparison, and they were clustered in advance to remove redundancy (resulting in
n = 18,383). Likewise, also viral RefSeq sequences larger than 1 kb (n = 12,681) were clustered in advance
(resulting in n = 10,313). The GVD is already nonredundant (95% identity over 70% or 100% coverage
depending on the type of virus) and consists of 33,242 viral genomes.
Prevalence of viral genomes across subjects worldwide. The prevalence of the genomes identi-
fied in the DEVoC in other subjects was assessed by mapping publicly available SRA data sets from 26
previously published human gut viral metagenomic studies (24–34, 65, 66, 91–103) and one unpub-
lished study from our lab to the DEVoC using the Burrows-Wheeler Aligner (BWA) (v2.0pre2) (104). Reads
were trimmed before mapping using Trimmomatic (v0.63; removing WTA2 and Nextera primers with
the parameters 30:10:1:true and the following quality trimming parameters: HEADCROP:19 LEADING:15
TRAILING:15 SLIDINGWINDOW:4:20 MINLEN:50) (76).
An overview of all included studies is available in Table S5. Studies were selected based on a
PubMed search in December 2019 searching for “human gut/fecal/enteric viromes.” Studies using tar-
geted sequencing or not using viral enrichment were excluded, as well as studies for which raw
sequencing reads and/or metadata (subject ID, age group, health status, and geographic region of inclu-
sion) were unavailable. The metadata were curated by screening the original article’s subject recruit-
ment section, supplementary tables, and/or the information association with the BioSample/SRA entry.
As the gut virome is relatively stable over time (29), multiple samples from the same subject were
pooled, except for patients undergoing fecal microbiota transplantation (FMT), for which only the base-
line sample (before FMT) was included, if available (33, 34, 92). Two studies sequenced pools of multiple
subjects, and for further analysis, these pools are regarded as one subject (91, 103). In total, 1,880 sam-
ples from 1,181 subjects (of which 490 were sequenced in 92 pools) were assessed. The subjects ranged
in age from 0 (24, 25, 65, 103) to 99 (34) years old and originated from different geographical locations
(13 countries across 4 continents). Besides healthy subjects, subjects suffering from inflammatory bowel
disease (IBD) (30–32, 92, 101), C. difficile infection (CDI) (33, 34), diarrhea (91), malnutrition (105), HIV
(100), type 1 diabetes (T1D) (65, 94), and colorectal cancer (CRC) (93) and subjects undergoing hemato-
poietic stem cell transplantation (HSCT) (95) were also included. A viral sequence was considered pres-
ent in a subject if it was covered for more than 70% of its length by reads from the subject.
CrAss-like phage genome. To determine to which proposed genus/subfamily the prevalent crAss-
like phage genome belongs (PG2), its genome is clustered with the 249 genomes from the crAss-like
phage data set of Guerin et al. (70) using ClusterGenomes (89) at 95% identity over 80% coverage.
LoVEphage genome. To investigate the genetic diversity of the LoVEphage, we attempted to
retrieve (near-)complete genomes from samples in which the LoVEphage was present. For the Danish
samples, scaffolds longer than 50 kb clustering together with the LoVEphage (see above) were selected.
All SRAs of subjects in which the LoVEphage was covered by reads for at least 70% of its length were
quality-trimmed using Trimmomatic (76) (same settings as before) and assembled using metaSPAdes
(v3.11.1; parameters -k 21,33,55,77) (106). A BLASTn search of the de novo assembled contigs was per-
formed against the reference LoVEphage (E value, 1e-10) (81). All contigs larger than 50 kb, which cov-
ered the reference genome for at least 70% with a similarity of .70%, were selected. Incomplete
genomes were completed using additional smaller scaffolds and/or individual quality-filtered reads (af-
ter mapping to the reference LoVEphage using BWA [104]), resulting in 18 additional complete
LoVEphage genomes. Cenote-Taker 2 (v2.0.1) was used to predict and annotate ORFs on the complete
LoVEphage-like genomes (same settings as before) (49). All 61 proteins that showed more than 70%
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identity over 70% coverage and were present in all 19 LoVEphage-like genomes were aligned individu-
ally using MAFFT (v7.464; with automatic alignment strategy selection) (107). The individual protein
alignments were concatenated and trimmed using trimAl (v1.4; parameter, -gappyout) (108). Maximum-
likelihood trees were generated using RAxML (v8.2.12; parameters, -f a with 1,000 bootstraps and auto-
matic amino acid substitution model selection) (109).
Ecological analyses, statistical analyses, and visualization. All ecological and statistical analyses,
as well as visualizations, were done in R (http://www.R-project.org; v3.6.0). Viral reads were subsampled
to a depth of 176,256 viral reads/sample, removing 21 samples with fewer viral reads, to allow unbiased
characterization of the gut virome across the samples, as virome sequencing depth is equal. Random
subsampling was done using the “rarefy_even_depth” function of the phyloseq package (v1.28.0) (110).
Phageome analyses were conducted on phage relative abundances, while analyses of the eukaryotic
viruses and at the protein level were performed on absence/presence profiles. Alpha-diversity indices
(observed richness and Shannon’s diversity) were calculated using the vegan package (v2.6-7) (111).
Beta diversity was analyzed using the phyloseq package (v1.28.0) (110). Principal-coordinate analysis
(PCoA) was used to visualize Jaccard distance. PERMANOVA was calculated using the “adonis” function
from the vegan package. Medians of two groups were compared using the Wilcoxon test. Proportions of
two groups were compared using the chi-squared test corrected for multiple testing using the
Bonferroni method. Prevalences of the selected phage genomes across multiple sample subsets were
compared using the Kruskal-Wallis test, after which post hoc Wilcoxon signed-rank tests (paired) were
performed on each pair of groups corrected for multiple testing using the Holm method. Multiple pro-
portions were compared using the test of equal proportions (prop.test in R), followed by post hoc tests
of equal proportions on each pair of groups corrected for multiple testing using the Holm method. The
genomic structure of individual phage genomes was visualized using the GenoPlotR package (v0.8.9)
(112), the Venn diagrams using the VennDiagram package (v1.6.20) (113), and the phylogenetic trees
using the ggtree package (v1.16.6) (114). Other figures were generated using the ggplot2 package
(v3.3.2) (115).
Data availability. The virome sequencing reads supporting the conclusions of this article are in the
Sequence Read Archive (SRA) with accession numbers PRJNA723467 (pediatric cohort) and
PRJNA722819 (adult cohort). The DEVoC and its encoded genes, annotations, and normalized counts are
available at https://doi.org/10.5281/zenodo.5173012. The LoVEphage genomes assembled from the
above-mentioned BioProjects are available in GenBank under accession no. MW660583, MZ919976,
MZ919981, and MZ919987. The scripts used to perform the analysis and make figures starting from the
abundance table are available at https://github.com/Matthijnssenslab/ViromeCatalogue.
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